Framingham Heart Study Bibliography

back to Framingham Main Bibliography Page back to Framingham Home Page

Years 1950-1979


  1. Wu M, Ware JH. On the use of repeated measurements in regression analysis with dichotomous responses. Biometrics 1979;35:513-21.

  2. Schneider JF, Thomas HEJ, Kreger BE, McNamara PM, Kannel WB. Newly acquired left bundle-branch block: the Framingham Study. Ann.Intern.Med. 1979;90:303-10.

  3. Kannel WB. Office evaluation of coronary candidates. Hosp.Med. 1979;38-50.

  4. Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of artheriosclerotic disease. Ann.Intern.Med. 1979;90:85-91.

  5. Kannel WB, Gordon T. Physiological and medical concomitants of obesity: the Framingham Study, In: Bray GA, editor. Obesity in America. Bethesda: U.S. Department of Health, Education, and Welfare, Public Health Service; 1979. p. 125-63.

  6. Kannel WB, Thom TJ. Implications of the recent decline in cardiovascular mortality. Cardiovasc Med. 1979;4:983-97.

  7. Kannel WB. Epidemiology and prognosis in hypertension, In: Roberts RH, editor. Theories and Use of B-blockade in Hypertension and Angina.Symposia specialists Inc.; 1979. p. 39-51.

  8. Kannel WB. (Part 2) CME Medicine. Risk factors in coronary disease-disease update. This is not a duplicate for CME Medicine Part 1, 3 ed. Wiley Medical; 1979. p. 1-6.

  9. Kannel WB. (Part 1) CME medicine. Risk factors in coronary disease-disease update, 3 ed. Wiley Medical; 1979. p. 1-5.

  10. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham Study. Circulation 1979;59:8-13.

  11. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham Study. JAMA 1979;241:2035-38.

  12. Kannel WB, Gordon T, Castelli WP. Obesity, lipids, and glucose intolerance. The Framingham Study. Am.J.Clin.Nutr. 1979;32:1238-45.

  13. Kannel WB, Sorlie PD, McNamara PM. Prognosis after initial myocardial infarction: the Framingham Study. Am.J.Cardiol. 1979;44:53-59.

  14. Kannel WB. Possible hazards of oral contraceptive use. Circulation 1979;60:490-91.

  15. Kannel WB, Sorlie PD. Some health benefits of physical activity. The Framingham Study. Arch.Intern.Med. 1979;139:857-61.

  16. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families. The Framingham offspring study. Am.J.Epidemiol. 1979;110:281-90.

  17. Kannel WB, Castelli WP. Is the serum total cholesterol an anachronism? Lancet 1979;2:950-51.

  18. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care 1979;2:120-26.

  19. Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham Study. Ann.Intern.Med. 1979;90:85-91.

  20. Hjortland MC, Feinleib M. Epidemiologic relationships of alcohol intake and coronary heart disease: result from NHLBI programs, In: Avogaro P, Sirtori CR, Tremoli E, editors. Metabolic Effects of Alcohol.North-Holland biomedical press; 1979. p. 393-403.

  21. Havlik RJ, Garrison RJ, Feinleib M, Kannel WB, Castelli WP, McNamara PM. Blood pressure aggregation in families. Am.J.Epidemiol. 1979;110:304-12.

  22. Feinleib M, Garrison RJ. The contribution of family studies to the partitioning of population variation of blood pressure, Genetic Analysis of Common Diseases: Applications to Predictive Factors in Coronary Disease. New York: Alan R. Liss, Inc.; 1979. p. 653-73.

  23. Halperin M, Wu M, Gordon T. Genesis and interpretation of differences in distribution of baseline characteristics between cases and non-cases in cohort studies. J.Chronic.Dis. 1979;32:483-91.

  24. Gresham GE, Phillips TF, Wolf PA, McNamara PM, Kannel WB, Dawber TR. Epidemiologic profile of long-term stroke disability: the Framingham Study. Arch.Phys.Med.Rehabil. 1979;60:487-91.

  25. Gordon T, Kannel WB, Halperin M. Predictability of coronary heart disease. J.Chronic.Dis. 1979;32:427-40.

  26. Garrison RJ, Castelli WP, Feinleib M, Kannel WB, Havlik RJ, Padgett SJ et al. The association of total cholesterol, triglycerides and plasma lipoprotein cholesterol levels in first degree relatives and spouse pairs. Am.J.Epidemiol. 1979;110:313-21.

  27. Feinleib M, Garrison RJ, Stallones L, Kannel WB, Castelli WP, McNamara PM. A comparison of blood pressure, total cholesterol and cigarette smoking in parents in 1950 and their children in 1970. Am.J.Epidemiol. 1979;110:291-303.

  28. Feinleib M, Kannel WB, Tedeschi CG, Landau TK, Garrison RJ. The relation of antemortem characteristics to cardiovascular findings at necropsy--the Framingham Study. Atherosclerosis 1979;34:145-57.

  29. Wolf PA, Kannel WB, Dawber TR. Prospective investigations: the Framingham Study and the epidemiology of stroke. Adv.Neurol. 1978;19:107-20.

  30. Wolf PA, Dawber TR, Kannel WB. Heart disease as a precursor of stroke. Adv.Neurol. 1978;19:567-77.

  31. Wolf PA, Dawber TR, Thomas HEJ, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham Study. Neurology 1978;28:973-77.

  32. Milton RC. The Framingham Eye Study. Sight Sav.Rev. 1978;48(1):29-36.

  33. McNamara PM, Hjortland MC, Kannel WB, Gordon T. Natural history of menopause: the Framingham Study. J.Contin.Ed.Obstet.Gynecol. 1978;20:27-35.

  34. Kannel WB. Further findings from Framingham. Med.Times 1978;106:97-103.

  35. Kannel WB, Sorlie PD, Gill E. Epidemiologische aspekte der angina pectoris, In: Gill E, editor. Angina pectoris. Pravention, Nichtoperative langzeitbehandlung und rehabilitation. Stuttgart, New York: Gustav Fischer Verlag; 1978. p. 249-74.

  36. Kannel WB. Status of coronary heart disease risk factors. J.Nutr.Ed. 1978;10(1):10-14.

  37. Kannel WB. Recent findings of the Framingham Study, Resident and Staff Physician, 24 ed. 1978. p. 56-71.

  38. Kannel WB. Recent findings from the Framingham Study--I. Med.Times 1978;106:23-27.

  39. Kannel WB, Sorlie PD. Utility of conventional risk factors in evaluation of patients with coronary disease. Cleve.Clin.Q. 1978;45:1-4.

  40. Kannel WB. [Some accomplishments of the Framingham Study (author's transl)]]. Przegl.Lek. 1978;35:275-85.

  41. Kannel WB, Sorlie PD. Remission of clinical angina pectoris: the Framingham Study. Am.J.Cardiol. 1978;42:119-23.

  42. Kannel WB, Wolf PA, Dawber TR. Hypertension and cardiac impairments increase stroke risk. Geriatrics 1978;33:71-83.

  43. Kannel WB, Gordon T. Evaluation of cardiovascular risk in the elderly: the Framingham Study. Bull.N.Y.Acad.Med. 1978;54:573-91.

  44. Kannel WB. Hypertension, blood lipids, and cigarette smoking as co-risk factors for coronary heart disease. Ann.N.Y.Acad.Sci. 1978;304:128-39.

  45. Kannel WB. Oral contraceptive hypertension and thromboembolism. Int.J.Gynaecol.Obstet. 1978;16:466-72.

  46. Haynes SG, Levine S, Scotch N, Feinleib M, Kannel WB. The relationship of psychosocial factors to coronary heart disease in the Framingham Study. I. Methods and risk factors. Am.J.Epidemiol. 1978;107:362-83.

  47. Haynes SG, Feinleib M, Levine S, Scotch N, Kannel WB. The relationship of psychosocial factors to coronary heart disease in the Framingham Study. II. Prevalence of coronary heart disease. Am.J.Epidemiol. 1978;107:384-402.

  48. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann.Intern.Med. 1978;89:157-61.

  49. Gillum RF, Fabsitz R, Feinleib M, Wolf PA, Margolis JR, Brasch RC. Community surveillance for cerebrovascular disease: the Framingham Cardiovascular Disease Survey. Public Health Rep. 1978;93:438-42.

  50. Garrison RJ, Kannel WB, Feinleib M, Castelli WP, McNamara PM, Padgett SJ. Cigarette smoking and HDL cholesterol: the Framingham Offspring Study. Atherosclerosis 1978;30:17-25.

  51. Wolf PA, Dawber TR, Thomas HE, Colton TL, Kannel WB. Epidemiology of stroke, In: Thompson R.A., Green J.R., editors.. New York: Raven Press; 1977. p. 5-19.

  52. Williams RR, McIntire KR, Waldmann TA, Feinleib M, Go VL, Kannel WB et al. Tumor-associated antigen levels (carcinoembryonic antigen, human chorionic gonadotropin, and alpha-fetoprotein) antedating the diagnosis of cancer in the Framingham Study. J.Natl.Cancer Inst. 1977;58:1547-51.

  53. Schneider JF, Thomas HE, Kannel WB. Precordial T wave vectors in the detection of coronary heart disease. The Framingham Study. Am.Heart J. 1977;94:568-72.

  54. Kannel WB. I segni premonitori della morte improvvisa coronarics lo studio di Framingham, Cardiologia preventiva atti del corso internazionale.Piccin Editore; 1977. p. 352-74.

  55. Kannel WB. Office estimation of coronary vulnerability, Medical Digest, 23 ed. 1977. p. 11-15.

  56. Kannel WB. Preclinical ECG precursors of cardiovascular disease, Primary Cardiology. 1977. p. 27-31.

  57. Kannel WB. Preventive cardiology. What should the clinician be doing about it? Postgrad.Med. 1977;61:74-85.

  58. Kannel WB, Gordon T, McGee DL. Diuretics and serum-cholesterol [letter]]. Lancet 1977;1:1362-63.

  59. Kannel WB. Prevention of heart disease in the young coronary candidate. Prim.Care 1977;4:229-43.

  60. Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton TL, Nickerson RS et al. The Framingham Eye Study: Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am.J.Epidemiol. 1977;106:33-41.

  61. Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton TL, Nickerson RS et al. The Framingham Eye Study: Outline and major prevalence findings. Am.J.Epidemiol. 1977;106:17-32.

  62. Gordon T, Castelli WP, Hjortland MC, Kannel WB. The prediction of coronary heart disease by high-density and other lipoproteins: An historical perspective, In: Rifkind BM, Levy RI, editors. Hyperlipidemia: Diagnosis and Therapy. (Publ): Grune & Stratton, Inc.; 1977. p. 71-78.

  63. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am.J.Med. 1977;62:707-14.

  64. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham Study. Ann.Intern.Med. 1977;87:393-97.

  65. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. Predicting coronary heart disease in middle-aged and older persons. The Framingham Study. JAMA 1977;238:497-99.

  66. Dawber TR, Wolf PA, Colton TL, Nickerson RJ. Risk factors: comparison of the biological data in myocardial and brain infarctions, In: Zulch KJ, Kauffmann W, Hossman KA, Hossman V, editors. Brain and Heart Infarct. Berlin: Heildelberg, Springer-Verlag; 1977. p. 226-51.

  67. Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB et al. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation 1977;55:767-72.

  68. Castelli WP, Cooper GR, Doyle JT, Garcia-Palmieri MR, Gordon T, Hames CG et al. Distribution of triglyceride and total, LDL and HDL cholesterol in several populations: a cooperative lipoprotein phenotyping study. J.Chronic.Dis. 1977;30:147-69.

  69. Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB et al. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet 1977;2:153-55.

  70. Margolis JR, Gillum RF, Feinleib M, Brasch RC, Fabsitz R. Community surveillance for coronary heart disease: the Framingham Cardiovascular Disease Survey. Comparisons with the Framingham Heart Study and previous short-term studies. Am.J.Cardiol. 1976;37:61-67.

  71. Kannel WB. Diabetes and cardiovascular disease - The Framingham Study: 18- year followup, Cardiology Digest. 1976. p. 11-16.

  72. Kannel WB. Brain infarction. The Framingham Study, Proceedings of the Medical Advisory Council, Cardiovascular Group Meeting. Tokyo: 1976. p. 7-16.

  73. Kannel WB. Prevention of cardiovascular disease, In: Harvey WP, de Leon ACJ, Leonard JJ, Marcus FI, O'Rourke RA, Roberts WC, editors. Current Problems in Cardiology, 4 ed. Chicago: Year book medical publishers, inc.; 1976.

  74. Kannel WB. Long-term predictors of cardiovascular disease, In: Caneiro RD, Carvalho MA, editors. Infarto do miocardio e suas complicacoes. Rio de Janeiro: 1976. p. 13-23.

  75. Kannel WB. Some lessons in cardiovascular epidemiology from Framingham. Am.J.Cardiol. 1976;37:269-82.

  76. Kannel WB, McGee DL, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am.J.Cardiol. 1976;38:46-51.

  77. Kannel WB, Dawber TR, Sorlie PD, Wolf PA. Components of blood pressure and risk of atherothrombotic brain infarction: the Framingham Study. Stroke 1976;7:327-31.

  78. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham Study. Ann.Intern.Med. 1976;85:447-52.

  79. Kannel WB. The Framingham Study [letter]]. Br.Med.J. 1976;2:1255.

  80. Kannel WB. Recent highlights from the Framingham Study. Aust.N.Z.J.Med. 1976;6:373-86.

  81. Kannel WB. Prospects for prevention of atherosclerosis in the young. Aust.N.Z.J.Med. 1976;6:410-19.

  82. Hjortland MC, McNamara PM, Kannel WB. Some atherogenic concomitants of menopause: the Framingham Study. Am.J.Epidemiol. 1976;103:304-11.

  83. Gordon T, Sorlie PD, Kannel WB. Problems in the assessment of blood pressure: the Framingham Study. Int.J.Epidemiol. 1976;5:327-34.

  84. Gordon T, Kannel WB. Obesity and cardiovascular diseases: the Framingham Study. Clin.Endocrinol.Metab. 1976;5:367-75.

  85. Gillum RF, Feinleib M, Margolis JR, Fabsitz R, Brasch RC. Delay in the prehospital phase of acute myocardial infarction. Lack of influence on incidence of sudden death. Arch.Intern.Med. 1976;136:649-54.

  86. Gillum RF, Feinleib M, Margolis JR, Fabsitz R, Brasch RC. Community surveillance for cardiovascular disease: the Framingham cardiovascular disease survey. Some methodological problems in the community study of cardiovascular disease. J.Chronic.Dis. 1976;29:289-99.

  87. Gillum RF, Feinleib M, Margolis JR, Fabsitz R, Brasch RC. The pre-hospital phase of acute myocardial infarction and sudden death. I. Prodromata of acute coronary events. Prev.Med. 1976;5:408-13.

  88. Garrison RJ, Havlik RJ, Harris RB, Feinleib M, Kannel WB, Padgett SJ. ABO blood group and cardiovacular disease. The Framingham Study. Atherosclerosis 1976;25:311-18.

  89. Doyle JT, Kannel WB, McNamara PM, Quickenton P, Gordon T. Factors related to suddenness of death from coronary disease: combined Albany-Framingham studies. Am.J.Cardiol. 1976;37:1073-78.

  90. Castelli WP. CHD risk factors in the elderly. Hosp.Pract. 1976;11:113-21.

  91. Brand RJ, Rosenman RH, Sholtz RI, Friedman M. Multivariate prediction of coronary heart disease in the western collaborative group study compared to the findings of the Framingham Study. Circulation 1976;53:348-55.

  92. Wolf PA. Hypertension as a risk factor for stroke, In: Whisnant JP, Sandok BA, editors. Cerebral Vascular Diseases.Grune and Stratton, Inc.; 1975. p. 105-12.

  93. Sacks FM, Castelli WP, Donner A, Kass EH. Plasma lipids and lipoproteins in vegetarians and controls. N.Engl.J.Med. 1975;292:1148-51.

  94. Sackett DL, Anderson GD, Milner R, Feinleib M, Kannel WB. Concordance for coronary risk factors among spouses. Circulation 1975;52:589-95.

  95. Nay P, Kannel WB, Castelli WP, McNamara PM. The omnicardiogram study of a proposed method for detecting coronary heart disease in an asymptomatic population. Circulation 1975;51:462-66.

  96. Kannel WB. Some considerations for achieving prevention of cardiovascular disease, International Symposium on Preventive Cardiology. Dublin: The Irish Heart Foundation; 1975. p. 133-47.

  97. Kannel WB. The natural history of coronary heart disease, International Symposium on Preventive Cardiology. Dublin: The Irish Heart Foundation; 1975. p. 9-16.

  98. Kannel WB, Gordon T. Some determinants of obesity and its impact as a cardiovascular risk factor, Recent Advances in Obesity Research, 1 ed. London: Newman publishing, Ltd.; 1975. p. 14-27.

  99. Kannel WB, Sorlie PD. Hypertension in Framingham, In: Paul O, editor. Epidemiology and Control of Hypertension. Miami: Symposia Specialists; 1975. p. 553-92.

  100. Kannel WB, Doyle JT, McNamara PM, Quickenton P, Gordon T. Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation 1975;51:606-13.

  101. Kannel WB. Role of blood pressure in cardiovascular disease: the Framingham Study. Angiology 1975;26:1-14.

  102. Kannel WB, Wolf PA, Dawber TR. An evaluation of the epidemiology of atherothrombotic brain infarction. Milbank Mem.Fund Q Health Soc. 1975;53:405-48.

  103. Gresham GE, Fitzpatrick TE, Wolf PA, McNamara PM, Kannel WB, Dawber TR. Residual disability in survivors of stroke--the Framingham Study. N.Engl.J.Med. 1975;293:954-56.

  104. Gordon T, Kannel WB, Dawber TR, McGee DL. Changes associated with quitting cigarette smoking: the Framingham Study. Am.Heart J. 1975;90:322-28.

  105. Feinleib M, Kannel WB, Garrison RJ, McNamara PM, Castelli WP. The Framingham Offspring Study. Design and preliminary data. Prev.Med. 1975;4:518-25.

  106. Ederer F. The randomized controlled clinical trial. Am.J.Ophthalmol. 1975;79(3):768-75.

  107. Dawber TR. Risk factors for arterosclerotic disease. The Upjohn Co.; 1975.

  108. Ashley FWJ, Kannel WB, Sorlie PD, Masson R. Pulmonary function: relation to aging, cigarette habit, and mortality. Ann.Intern.Med. 1975;82:739-45.

  109. Rose G, Blackburn H, Keys A, Taylor HL, Kannel WB, Paul O et al. Colon cancer and blood-cholesterol. Lancet 1974;181-83.

  110. Peabody CN, Kannel WB, McNamara PM. Intermittent claudication. Surgical significance. Arch.Surg. 1974;109:693-97.

  111. Margolis JR, Gillum RF, Feinleib M, Brasch RC, Fabsitz R. Community surveillance for coronary heart disease: the Framingham Cardiovascular Disease Survey. Methods and preliminary results. Am.J.Epidemiol. 1974;100:425-36.

  112. Kannel WB. The role of cholesterol in coronary atherogenesis: the Framingham Study. Med.Clin.North Am. 1974;58:363-77.

  113. Kannel WB, Gordon T. Obesity and cardiovascular disease. The Framingham Study, In: Burland WL, Samuel PD, Yudkin J, editors. Obesity Symposium. Proceedings of a Servier Research Institute symposium held on December 1973. Edinburgh: Churchill Livingstone; 1974. p. 24-51.

  114. Kannel WB, Dawber TR. Hypertension as an ingredient of a cardiovascular risk profile. Br.J.Hos.Med. 1974;508-23.

  115. Kannel WB. The role of lipids and blood pressure in the development of coronary heart disease. The Framingham Study. G.Ital.Cardiol. 1974;4:123-37.

  116. Kannel WB, Seidman JM, Fercho W, Castelli WP. Vital capacity and congestive heart failure. The Framingham Study. Circulation 1974;49:1160-66.

  117. Kannel WB, Hjortland MC, Castelli WP. Role of diabetes in congestive heart failure: the Framingham Study. Am.J.Cardiol. 1974;34:29-34.

  118. Kannel WB, Gordon T, Dawber TR. Role of lipids in the development of brain infarction: the Framingham Study. Stroke 1974;5:679-85.

  119. Kannel WB. Role of blood pressure in cardiovascular morbidity and mortality. Prog.Cardiovasc.Dis. 1974;17:5-24.

  120. Gordon T. Hazards in the use of the logistic function with special reference to data from prospective cardiovascular studies. J.Chronic.Dis. 1974;27:97-102.

  121. Gordon T, Garcia-Palmieri MR, Kagan A, Kannel WB, Schiffman J. Differences in coronary heart disease in Framingham, Honolulu and Puerto Rico. J.Chronic.Dis. 1974;27:329-44.

  122. Gordon T, Kannel WB, McGee DL, Dawber TR. Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham Study. Lancet 1974;2:1345-48.

  123. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 1974;23:105-11.

  124. Dawber TR, Kagan A, Kannel WB. The Framingham Heart Study. Detection of factors increasing risk of coronary disease. Bethesda: U.S. Department of Health, Education, and Welfare; 1964.

  125. Dawber TR, Kannel WB, Gordon T. Coffee and cardiovascular disease. Observations from the Framingham Study. N.Engl.J.Med. 1974;291:871-74.

  126. Ashley FWJ, Kannel WB. Relation of weight change to changes in atherogenic traits: the Framingham Study. J.Chronic.Dis. 1974;27:103-14.

  127. Wolf PA, Kannel WB, McNamara PM, Gordon T. The role of impaired cardiac function in atherosthrombotic brain infarction: the Framingham Study. Am.J.Public Health 1973;63:52-58.

  128. Margolis JR, Kannel WB, Feinleib M, Dawber TR, McNamara PM. Clinical features of unrecognized myocardial infarction--silent and symptomatic. Eighteen year follow-up: the Framingham Study. Am.J.Cardiol. 1973;32:1-7.

  129. Kannel WB, Dawber TR. Hypertensive cardiovascular disease: the Framingham Study, In: Onesti G, Kim KE, Moyer JH, editors. Hypertension: Mechanisms and Management. New York: Grune & Stratton; 1973. p. 93-110.

  130. Kannel WB, Gordon T. Assessment of coronary vulnerability--the Framingham Study, In: Unknown, editor. Early Phases of Coronary Heart Disease. Skandia International Symposia, September 19-21, 1972. Stockholm: Nordiska Bokhandeins Forlag; 1973. p. 123-43.

  131. Kannel WB. Coronary profile: ethical considerations, In: Davies DF, Tchobanoff JB, editors. Health Evaluation; An Entry to the Health Care System. New York: Intercontinental Medical Book Corp.; 1973. p. 141-50.

  132. Kannel WB. The Natural History of Myocardial Infarction: The Framingham Study. Leiden, The Netherlands: Leiden University Press; 1973. p. 1-33.

  133. Kannel WB, Shurtleff D. The Framingham Study; cigarettes and the development of intermittent claudication. Geriatrics 1973;28:61-68.

  134. Kannel WB. Obesity and coronary heart disease. Nutrah 1973;1:1-4.

  135. Kannel WB. Rehabilitation of the hypertensive. Cardiac Rehabilitation 1973;3:51-54.

  136. Kannel WB, Banas JS, Schiffman J. The natural history of coronary diseases: Implications for prophylactic surgical revascularization of the myocardium, In: Russek HI, editor. The Paul D. White Symposium on Cardiovascular Disease. Baltimore: The William and Wilkins Co.; 1973. p. 190-205.

  137. Kannel WB, Dawber TR, Gordon T. Controllable major contributors to coronary risk: the Framingham Study, The Paul D. White Symposium on Cardiovascular Disease. Baltimore: The Williams and Wilkins Co.; 1973. p. 120-32.

  138. Gordon T, Kannel WB. The effects of overweight on cardiovascular diseases. Geriatrics 1973;28:80-88.

  139. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Cardiovascular complications in diabetics. Adv.Metab.Disord. 1973;Suppl 2:493-99.

  140. Dawber TR, Thomas HEJ, McNamara PM. Characteristics of the dicrotic notch of the arterial pulse wave in coronary heart disease. Angiology 1973;24:244-55.

  141. Lawrence T, McKee PA, Castelli WP, McNamara PM, Kannel WB. Heart failure and hypertension. (letter to the editor). N.Engl.J.Med. 1972;286:667-68.

  142. Kannel WB, Dawber TR. Contributors to coronary risk implications for prevention and public health: the Framingham Study. Heart Lung 1972;1:797-810.

  143. Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M. Role of blood pressure in the development of congestive heart failure; the Framingham Study. N.Engl.J.Med. 1972;287:781-87.

  144. Kannel WB, Gordon T, Wolf PA, McNamara PM. Hemoglobin and the risk of cerebral infarction: the Framingham Study. Stroke 1972;3:409-20.

  145. Kannel WB, Feinleib M. Natural history of angina pectoris in the Framingham Study; prognosis and survival. Am.J.Cardiol. 1972;29:154-63.

  146. Kannel WB, Castelli WP. The Framingham Study of coronary disease in women. Med.Times 1972;100:173-84.

  147. Kannel WB, Dawber TR. Atherosclerosis as a pediatric problem. J.Pediatr. 1972;80,Pt2:544-54.

  148. Gordon T, Kannel WB. The prospective study of cardiovascular disease, In: Stewart GT, editor. Trends in Epidemiology; Application to Health Service Research and Training. Springfield, IL: Charles C. Thomas; 1972. p. 189-211.

  149. Gordon T, Kannel WB. Predisposition to atherosclerosis in the head, heart, and legs; the Framingham Study. JAMA 1972;221:661-66.

  150. Gordon T, Kannel WB. Multiple contributors to coronary risk implications for screening and prevention. J.Chronic.Dis. 1972;25:561-65.

  151. Dawber TR, Kannel WB. Current status of coronary prevention. Lessons from the Framingham Study. Prev.Med. 1972;1:499-512.

  152. Sorlie PD. Changes in successive measurements and the development of disease: the Framingham Study. J.Chronic.Dis. 1971;24:349-61.

  153. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham Study. N.Engl.J.Med. 1971;285:1441-46.

  154. Kannel WB, Shurtleff D. The natural history of arteriosclerosis obliterans, In: Brest AN, Gifford RW, editors. Cardiovascular Clinics; Peripheral Vascular Disease. Philadelphia: Davis FA; 1971. p. Vol 3:37-Vol 3:52.

  155. Kannel WB. Medical evaluation for physical exercise programs, In: Morse RL, editor. Exercise and the Heart. Springfield, IL: Charles C. Thomas; 1971. p. 79-97.

  156. Kannel WB. Lipid profile and the potential coronary victim. Am.J.Clin.Nutr. 1971;24:1074-81.

  157. Kannel WB. Current status of the epidemiology of brain infarction associated with occlusive arterial disease. Stroke 1971;2:295-318.

  158. Kannel WB, Gordon T, Sorlie PD, McNamara PM. Physical activity and coronary vulnerability: the Framingham Study. Cardiol Digest 1971;6:28-40.

  159. Kannel WB, Castelli WP, Verter JI, McNamara PM. Relative importance of factors of risk in the pathogenesis of coronary heart disease: the Framingham Study, In: Russek HI, Zohman BL, editors. A Medical-Surgical Symposium Sponsored by the American College of Cardiology and St. Barnabas Hospital, New York City, December 13-15, 1968. Philadelphia: Lippincott; 1971. p. 97-114.

  160. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease; the Framingham Study. Am.J.Cardiol. 1971;27:335-45.

  161. Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease; the Framingham Study. Ann.Intern.Med. 1971;74:1-12.

  162. Kannel WB, Garcia MJ, McNamara PM, Pearson G. Serum lipid precursors of coronary heart disease. Hum.Pathol. 1971;2:129-51.

  163. Kannel WB, Dawber TR. The prudent management of coronary-prone subject; coping with risk factors, In: Russek HI, Zohman BL, editors. Cardiovascular Therapy; the Art and the Science. Baltimore: Williams and Wilkins Co.; 1971. p. 225-36.

  164. Kannel WB. Habits and heart disease, In: Palmore E, Jeffers FC, editors. Prediction of Life Span. Lexington: D.C. Health; 1971. p. 61-70.

  165. Kannel WB. Cholesterol: a potent contributor to atherogenesis? Med.Counterpoint 1971;3:31-42.

  166. Kannel WB, Sorlie PD, McNamara PM. The relation of physical activity to risk of coronary heart disease. The Framingham Study, In: Larsen OA, Malmborg RO, editors. Coronary Heart Disease and Physical Fitness. Proceedings of a Symposium Held in Copenhagen, September 2-5, 1970. Baltimore: University Park Press; 1971. p. 256-60.

  167. Kannel WB, Shurtleff D. The natural history of arteriosclerosis obliterans. Cardiovasc.Clin. 1971;3:37-52.

  168. Gordon T, Kannel WB. Premature mortality from coronary heart disease; the Framingham Study. JAMA 1971;215:1617-25.

  169. Wolf PA, Kannel WB, McNamara PM. Occult impaired cardiac function, congestive heart failure, and risk of thrombotic stroke: the Framingham Study. Neurology 1970;20:373.

  170. Kannel WB. Physical exercise and lethal atherosclerotic disease. N.Engl.J.Med. 1970;282:1153-54.

  171. Kannel WB. The Framingham Study and chronic disease prevention. Hosp.Pract. 1970;5:78-94.

  172. Kannel WB, Wolf PA, Verter JI, McNamara PM. Epidemiologic assessment of the role of blood pressure in stroke; the Framingham Study. JAMA 1970;214:301-10.

  173. Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease; the Framingham Study. Ann.Intern.Med. 1970;72:813-22.

  174. Kannel WB, Skinner JJJ, Schwartz MJ, Shurtleff D. Intermittent claudication; incidence in the Framingham Study. Circulation 1970;41:875-83.

  175. Kannel WB. Coronary heart disease epidemiology: implications for practice. The Framingham Study. Aktuel.Probl.Angiol. 1970;7:82-97.

  176. Kannel WB. The epidemiology of coronary heart disease: methodologic considerations. The Framingham Study. Aktuel.Probl.Angiol. 1970;7:25-42.

  177. Kannel WB, McNamara PM, Feinleib M, Dawber TR. The unrecognized myocardial infarction; fourteen-year follow-up experience in the Framingham Study. Geriatrics 1970;25:75-87.

  178. Gordon T, Kannel WB. The Framingham, Massachusetts, Study twenty years later, In: Kessler II, Levin ML, editors. The Community as an Epidemiologic Laboratory; A Casebook of Community Studies. Baltimore: Johns Hopkins Press; 1970. p. 123-46.

  179. Weiss AN, Jobe CL, Gordon T, Lange PH, Frommer PL. Relationship of premature ventricular contractions and left ventricular hypertrophy to sudden cardiac death. Circulation 1969;40:suppl 3:III-213.

  180. Kannel WB, Castelli WP, McNamara PM, Sorlie PD. Some factors affecting morbidity and mortality in hypertension; the Framingham Study. Milbank Mem.Fund Q Health Soc. 1969;47,Pt2:116-42.

  181. Kannel WB, Castelli WP, McNamara PM. Serum lipid fractions and risk of coronary heart disease; the Framingham Study. Minn.Med. 1969;52:1225-30.

  182. Kannel WB, McNamara PM. The evidence for excess risk in coronary disease. Minn.Med. 1969;52:1197-201.

  183. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram; prevalence, incidence, and mortality in the Framingham Study. Ann.Intern.Med. 1969;71:89-105.

  184. Kannel WB, Schwartz MJ, McNamara PM. Blood pressure and risk of coronary heart disease: the Framingham Study. Dis.Chest 1969;56:43-52.

  185. Kannel WB, Pearson G, McNamara PM. Obesity as a force of morbidity, In: Heald FP, editor. Adolescent Nutrition and Growth. New York: Appleton-Century-Crofts; 1969. p. 51-71.

  186. Havlik RJ, Feinleib M, Garrison RJ, Kannel WB. Blood-groups and coronary heart disease. Lancet 1969;2:269-70.

  187. Hall AP. Observations on subjects developing a positive test for rheumatoid factor in a prospective study. Arthritis Rheum. 1969;12:301.

  188. Damon A, Damon ST, Harpending HC, Kannel WB. Predicting coronary heart disease from body measurements of Framingham males. J.Chronic.Dis. 1969;21:781-802.

  189. Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules; final report of a 15-year study of the incidence of thyroid malignancy. Ann.Intern.Med. 1968;69:537-40.

  190. Kannel WB, Castelli WP, McNamara PM. Epidemiology of acute myocardial infarction; the Framingham Study. Med.Today 1968;2:56-71.

  191. Kannel WB, Castelli WP, McNamara PM. Cigarette smoking and risk of coronary heart disease. Epidemiologic clues to pathogensis. The Framingham Study. Natl.Cancer Inst.Monogr. 1968;28:9-20.

  192. Dawber TR, Thomas HEJ. Prophylaxis of coronary heart disease, stroke, and peripheral atherosclerosis. Ann.N.Y.Acad.Sci. 1968;149:1038-57.

  193. Dawber TR, Kannel WB. The early diagnosis of coronary heart disease, In: Sharp CLEH, Keen H, editors. Presymptomatic Detection and Early Diagnosis: A Critical Appraisal. London: Pitman Medical; 1968. p. 257-81.

  194. Framingham Monograph. Washington DC: DHEW (NIH); 1968.

  195. Walker SH, Duncan DB. Estimation of the probability of an event as a function of several independent variables. Biometrika 1967;54:167-79.

  196. Truett J, Cornfield J, Kannel WB. A multivariate analysis of the risk of coronary heart disease in Framingham. J.Chronic.Dis. 1967;20:511-24.

  197. Thomas HEJ, Kannel WB, McNamara PM. Obesity: a hazard to health. Med.Times 1967;95:1099-106.

  198. Kannel WB, Castelli WP, McNamara PM. The coronary profile: 12-year follow-up in the Framingham Study. J.Occup.Med. 1967;9:611-19.

  199. Kannel WB, Brand FN, Skinner JJJ, Dawber TR, McNamara PM. The relation of adiposity to blood pressure and development of hypertension; the Framingham Study. Ann.Intern.Med. 1967;67:48-59.

  200. Kannel WB, Troy BL, McNamara PM. Epidemiology of Stroke, 1607 ed. Washington, DC, US Govt. Printing Office: US Dept of Health, Education, and Welfare, Public Health Service; 1967. p. 1-8.

  201. Kannel WB, LeBauer EJ, Dawber TR, McNamara PM. Relation of body weight to development of coronary heart disease: the Framingham Study. Circulation 1967;35:734-44.

  202. Kannel WB. Habitual level of physical activity and risk of coronary heart disease: the Framingham Study. Can.Med.Assoc.J. 1967;96:811-12.

  203. Kannel WB, Castelli WP, Revotskie N, McNamara PM. Profile of the coronary-prone individual. Assessment of risk of developing coronary heart disease. The Framingham Study. Proc.Annu.Meet.Med.Sect.Am.Life Conv. 1967;55:74-99.

  204. Hall AP, Barry PE, Dawber TR, McNamara PM. Epidemiology of gout and hyperuricemia; a long-term population study. Am.J.Med. 1967;42:27-37.

  205. Friedman GD, Kannel WB, Dawber TR, McNamara PM. An evaluation of follow-up methods in the Framingham Heart Study. Am.J.Public Health Nations.Health 1967;57:1015-24.

  206. Dawber TR, McNamara PM. Coronary heart disease: identification of susceptible individuals, In: Brest AN, Moyer JH, editors. Atherosclerotic Vascular Disease. A Hahnemann Symposium. New York: Appleton-Century-Crofts; 1967. p. 130-46.

  207. Dawber TR, Kannel WB, Kagan A, Donabedian RK, McNamara PM, Pearson G. Environmental factors in hypertension, In: Stamler J, Stamler R, Pullman TN, editors. The Epidemiology of Hypertension. Proceedings of an International Symposium sponsored by the Chicago Heart Association and the American Heart Association, Chicago, IL, February 3-7, 1964. New York: Grune & Stratton; 1967. p. 255-88.

  208. Thomas HEJ, Kannel WB, Dawber TR, McNamara PM. Cholesterol-phospholipid ratio in the prediction of coronary heart disease; the Framingham Study. N.Engl.J.Med. 1966;274:701-05.

  209. Kannel WB. An epidemiologic study of cerebrovascular disease, In: Millikan CH, Siekert RG, Whisnant JP, editors. Cerebral Vascular Diseases. Transactions of the Fifth Conference held under the Auspices of The American Neurological Association and The American Heart Association, Princeton, New Jersey, January 5-7, 1966. New York: Grune & Stratton; 1966. p. 53-66.

  210. Kannel WB. Habits and Coronary Heart Disease; The Framingham Heart Study. Washington, DC, US Govt Print Off: US Dept of Health, Education, and Welfare, Public Health Service Publ. No. 1515; 1966. p. 1-13.

  211. Kannel WB, Dawber TR, McNamara PM. Detection of the coronary-prone adult: the Framingham Study. J.Iowa.Med.Soc. 1966;56:26-34.

  212. Kahn HA, Dawber TR. The development of coronary heart disease in relation to sequential biennial measures of cholesterol in the Framingham Study. J.Chronic.Dis. 1966;19:611-20.

  213. Friedman GD, Kannel WB, Dawber TR. The epidemiology of gallbladder disease: observations in the Framingham Study. J.Chronic.Dis. 1966;19:273-92.

  214. Friedman GD, Kannel WB, Dawber TR, McNamara PM. Comparison of prevalence, case history and incidence data in assessing the potency of risk factors in coronary heart disease. Am.J.Epidemiol. 1966;83:366-78.

  215. Dawber TR, Kannel WB, Friedman GD. Vital capacity, physical activity and coronary heart disease, In: Raab W, editor. Prevention of Ischemic Heart Disease: Principles and Practice. Springfield, IL: Charles C Thomas; 1966. p. 254-65.

  216. Dawber TR, Kannel WB. The Framingham Study; an epidemiological approach to coronary heart disease. Circulation 1966;34:553-55.

  217. Kannel WB, Dawber TR, McNamara PM. Vascular disease of the brain - epidemiologic aspects: the Framingham Study. Am.J.Public Health 1965;55:1355-66.

  218. Kannel WB, Dawber TR, Thomas HEJ, McNamara PM. Comparison of serum lipids in the prediction of coronary heart disease. R.I.Med.J. 1965;48:243-50.

  219. Kannel WB, Widmer LK, Dawber TR. Gefahrdung durch coronare Herzkrankheit; Folgerungen fur die Praxis aus 10 Jahren Framingham-Studie. Susceptibility to coronary heart disease; preventive implications of 10 years of observation in the Framingham Study. Schweiz.Med.Wochenschr. 1965;95:18-24.

  220. Higgins ITT, Kannel WB, Dawber TR. The electrocardiogram in epidemiological studies; reproducibility, validity, and international comparison. Br.J.Prev.Soc.Med. 1965;19:53-68.

  221. Hall AP. Correlations among hyperuricemia, hypercholesterolemia, coronary disease and hypertension. Arthritis Rheum. 1965;8,pt1:846-52.

  222. Dawber TR. Heart attack--what's the risk? Today's Health 1965;43:62-64.

  223. Dawber TR, Kannel WB, McNamara PM, Cohen ME. An epidemiologic study of apoplexy ("strokes":). Observations in 5,209 adults in the Framingham Study on Association of Various Factors in the Development of Apoplexy. Trans.Am.Neurol.Assoc. 1965;90:237-40.

  224. Kannel WB, Dawber TR, Friedman GD, Glennon WE, McNamara PM. Risk factors in coronary heart disease; an evaluation of several serum lipids as predictors of coronary heart disease. Ann.Intern.Med. 1964;61:888-99.

  225. Kannel WB. Cigarette smoking and coronary heart disease. Ann.Intern.Med. 1964;60:1103-06.

  226. Doyle JT, Dawber TR, Kannel WB, Kinch SH, Kahn HA. The relationship of cigarette smoking to coronary heart disease; the second report of the combined experience of the Albany, NY, and Framingham, MA, studies. JAMA 1964;190:886-90.

  227. Dawber TR, Kannel WB, McNamara PM. The prediction of coronary heart disease, In: Moore SRJ, editor. Transactions of the Association of Life Insurance Medical Directors of America, Seventy-Second Annual Meeting, October 16, 1963, New York City. New York: Recording & Statistical Company; 1964. p. Vol 47:3-Vol 4734.

  228. Kannel WB, Barry PE, Dawber TR. Immediate mortality in coronary heart disease. The Framingham Study, Proceedings of the IV World Congress of Cardiology held in Mexico City, October 7-13, 1962. Coronary Insufficiency; Myocardial Infarction. Mexico: International Society of Cardiology; 1963. p. 176-88.

  229. Kagan A, Kannel WB, Dawber TR, Revotskie N. The coronary profile. Ann.N.Y.Acad.Sci. 1963;97:883-94.

  230. Dawber TR, Kannel WB, Lyell LP. An approach to longitudinal studies in a community: the Framingham Study. Ann.N.Y.Acad.Sci. 1963;107:539-56.

  231. Dawber TR, Kannel WB. Coronary heart disease as an epidemiology entity. Am.J.Public Health 1963;53:433-37.

  232. Dawber TR, Kannel WB, Friedman GD. The use of computers in cardiovascular epidemiology. Prog.Cardiovasc.Dis. 1963;5:406-17.

  233. Dawber TR. Coronary heart disease; morbidity in the Framingham Study and analysis of factors of risk. Bibl.Cardiol. 1963;13:9-24.

  234. Revotskie N, Kannel WB, Goldsmith JR, Dawber TR. Pulmonary function in a community sample. Am.Rev.Respir.Dis. 1962;86:907-11.

  235. Mann GV, Pearson G, Gordon T, Dawber TR. Diet and cardiovascular disease in the Framingham Study. I. Measurement of dietary intake. Clin.Nutr. 1962;11:200-25.

  236. Kannel WB, Dawber TR, Glennon WE, Thorne MC. Preliminary report: the determinants and clinical significance of serum cholesterol. Mass.J.Med.Tech. 1962;4:11-29.

  237. Kannel WB, Kagan A, Dawber TR, Revotskie N. Epidemiology of coronary heart disease; implications for the practicing physician. Geriatrics 1962;17:675-90.

  238. Kahn HA. Use of computers in analyzing Framingham data. Circ.Res. 1962;11:pt2:585-86.

  239. Kagan A, Dawber TR, Kannel WB, Revotskie N. The Framingham Study: a prospective study of coronary heart disease. Fed.Proc. 1962;21:pt 2:52-57.

  240. Gerende, L. J. Some methodological problems in the study of the natural history of blood pressure: an examination of the Framingham Study data. Ph.D.Dissertation , 201. 1962.
    Ref Type: Abstract

  241. Doyle JT, Dawber TR, Kannel WB, Heslin AS, Kahn HA. Cigarette smoking and coronary heart disease; combined experience of the Albany and Framingham studies. N.Engl.J.Med. 1962;266:796-801.

  242. Dawber TR, Kannel WB. Atherosclerosis and you: pathogenetic implications from epidemiologic observations. J.Am.Geriatr.Soc. 1962;10:805-21.

  243. Dawber TR, Kannel WB. Computers in epidemiologic research; uses in the Framingham Study. Circ.Res. 1962;11:pt 2:587-89.

  244. Dawber TR, Pearson G, Anderson P, Mann GV, Kannel WB, Shurtleff D et al. Dietary assessment in the epidemiologic study of coronary heart disease: the Framingham Study. Am.J.Clin.Nutr. 1962;11:226-34.

  245. Dawber TR, Kannel WB. Application of epidemiology of coronary heart disease to medical practice. Mod.Med. 1962;30:85-101.

  246. Dawber TR, Kannel WB, Revotskie N, Kagan A. The epidemiology of coronary heart disease--the Framingham enquiry. Proc.R.Soc.Med. 1962;55:265-71.

  247. Cornfield J. Joint dependence of risk of coronary heart disease on serum cholesterol and systolic blood pressure: a discriminant function analysis. Fed.Proc. 1962;21,pt 2:58-61.

  248. Cicchinelli, A. L. The composite of two Gaussian distributions as a model for blood pressure in man. Ph.D.Dissertation , 127. 1962.
    Ref Type: Abstract

  249. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes JI. Factors of risk in the development of coronary heart disease-- six year follow-up experience; the Framingham Study. Ann.Intern.Med. 1961;55:33-50.

  250. Kahn HA. A method for analyzing longitudinal observations on individuals in the Framingham Heart Study, In: Goldfield ED, editor. American Statistical Association, Proceedings of the Social Statistics Section, 1961. Washington, DC: American Statistical Association; 1961.

  251. Dawber TR, Kannel WB. Susceptibility to coronary heart disease. Mod.Concepts Cardiovasc.Dis. 1961;30:671-75.

  252. Dawber TR, Kannel WB, Pearson G, Shurtleff D. Assessment of diet in the Framingham Study; methodology and preliminary observations. Health News 1961;38:4-6.

  253. Cornfield J, Gordon T, Smith WW. Quantal response curves for experimentally uncontrolled variables. Bull.Int.Stat.Inst. 1961;38,pt 3:97-115.

  254. Dawber TR. Summary of recent literature regarding cigarette smoking and coronary heart disease. Circulation 1960;22:164-66.

  255. Stokes JI, Dawber TR. The "silent coronary": the frequency and clinical characteristics of unrecognized myocardial infarction in the Framingham Study. Ann.Intern.Med. 1959;50:1359-69.

  256. Kagan A, Gordon T, Kannel WB, Dawber TR. Blood pressure and its relation to coronary heart disease in the Framingham Study, Hypertension Volume VII. Drug Action, Epidemiology and Hemodynamics. Proceedings of the Council for High Blood Pressure Research, American Heart Association. New York: American Heart Association; 1959. p. 53-81.

  257. Gordon T, Moore FEJ, Shurtleff D, Dawber TR. Some methodologic problems in the long-term study of cardiovascular disease: observations on the Framingham Study. J.Chronic.Dis. 1959;10:186-206.

  258. Dawber TR, Kannel WB, Revotskie N, Stokes JI, Kagan A, Gordon T. Some factors associated with the development of coronary heart disease; six years' follow-up experience in the Framingham Study. Am.J.Public Health 1959;49:1349-56.

  259. Kannel WB, Dawber TR, Cohen ME. The electrocardiogram in neurocirculatory asthenia (anxiety, neurosis or neurasthenia): a study of 203 neurocirculatory asthenia patients and 757 healthy controls in the Framingham Study. Ann.Intern.Med. 1958;49:1351-60.

  260. Dawber TR, Kannel WB. An epidemiologic study of heart disease: the Framingham Study. Nutr.Rev. 1958;16:1-4.

  261. Dawber TR, Moore FEJ, Mann GV. Coronary heart disease in the Framingham Study. Am.J.Public Health 1957;47:pt. 2:4-24.

  262. Stokes JI, Dawber TR. Rheumatic heart disease in the Framingham Study. N.Engl.J.Med. 1956;255:1228-33.

  263. Vander JB, Gaston EA, Dawber TR. Significance of solitary nontoxic thyroid nodules; preliminary report. N.Engl.J.Med. 1954;251:970-73.

  264. Dawber TR, Kannel WB, Love DE, Streeper RD. The electrocardiogram in heart disease detection; a comparison of the multiple and single lead procedures. Circulation 1952;5:559-66.

  265. Dawber TR, Moore FEJ. Longitudinal study of heart disease in Framingham, Massachusetts: an interim report, Research in Public Health. Papers presented at the 1951 Annual Conference of the Milbank Memorial Health Fund. New York: Milbank Memorial Fund; 1952. p. 241-47.

  266. Dawber TR, Meadors GF, Moore FEJ. Epidemiological approaches to heart disease: the Framingham Study. Am.J.Public Health 1951;41:279-86.

back to Framingham Main Bibliography Page back to Framingham Home Page




Please send us your feedback, comments, and questions
by using the appropriate link on the page, Contact the NHLBI.

Note to users of screen readers and other assistive technologies: please report your problems here.